"Established in 2014, and formerly known as Southwest Retina Consultants, Southwest Eye Consultants is dedicated to providing the highest quality, most advanced medical and surgical eye care in the Four Corners region that includes southwest Colorado, New Mexico, Utah, and Arizona. Based in Durango, Colorado with satellite offices in Cortez, Colorado and Farmington, New Mexico, we serve the diverse population of the Four Corners region by providing state-of-the-art medical and surgical eye care with an emphasis on diseases of the retina, macula, vitreous, uvea, and cornea. Our specialty involves caring for conditions such as:"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Southwest Retina Consultants
During the past decade, Southwest Retina Consultants conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
2020-09-30
2021-07-31
Completed
316
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Southwest Retina Consultants
According to Clinical.Site data, the most researched conditions in "Southwest Retina Consultants" are
"Geographic Atrophy" (2 trials), "Macular Degeneration, Age-Related" (2 trials), "Neovascular Age-Related Macular Degeneration" (2 trials), "Age-Related Macular Degeneration" (1 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "Southwest Retina Consultants" in a lesser frequency.
Clinical Trials Intervention Types at Southwest Retina Consultants
Most popular intervention types in "Southwest Retina Consultants" are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Galegenimab" (2 trials), "Faricimab" (1 trials), "Intravitreal Injections of 10 mg/mL Ranibizumab" (1 trials), "Intravitreal Ranibizumab 0.5 mg Injection" (1 trials) and "LUCENTIS (ranibizumab injection)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Southwest Retina Consultants
The vast majority of trials in "Southwest Retina Consultants" are
8 trials for "All" genders.
Clinical Trials Status at Southwest Retina Consultants
Currently, there are NaN active trials in "Southwest Retina Consultants".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Southwest Retina Consultants,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Southwest Retina Consultants, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".